GridAI Technologies Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $27.8M
- Price
- $4.17
- % Change (Daily % change from the live per-ticker quote feed.)
- +10.03%
- Volume
- 311.6K
About
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Quick stats
Shares outstanding6.7M
Computed float5.9M
Float / shares88.7%
Cash runway (months)-4
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001604191
Websitehttps://www.grid-ai.com
AI Summary
AI-generated1/4
minorneutralother
GridAI Technologies Corp. to Present at the Market Movers Investor Summit
GridAI Technologies Corp. announced that Corporate Advisor Jérôme Cliche will present at the Market Movers Investor Summit on May 5, 2026.
The event will take place at 4:00 PM ET at the Bank of New York in New York City, featuring fireside chats with Alex Rodriguez and Grant Cardone.
The company describes itself as an AI-native energy orchestration platform focused on optimizing distributed energy resources and power infrastructure for data centers.